🔬 D-dimer

A blood test measuring fibrin degradation products, used as a sensitive but non-specific marker to rule out venous thromboembolism in low-probability patients.

The D-dimer is primarily indicated for the exclusion of Venous Thromboembolism (VTE), which includes Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). It should only be requested in patients where the clinical suspicion is low or intermediate, as determined by a validated scoring system like the Wells Score. It also has a role in the diagnosis of Disseminated Intravascular Coagulation (DIC).

D-dimer is measured via a venous blood sample, typically collected in a sodium citrate (blue top) tube. The laboratory uses automated immunoassays (usually latex agglutination or ELISA-based) that use monoclonal antibodies specifically targeting the D-dimer antigen. The D-dimer is a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis (specifically, the breakdown of cross-linked fibrin).

A normal D-dimer result is one that falls below the laboratory’s threshold (typically <500 ng/mL or FEU). This indicates that there is no significant active clot formation and subsequent breakdown occurring in the body. In the context of a low Wells score, this result has a negative predictive value of nearly 99% for VTE.

A negative D-dimer (below the reference cutoff) in a 'low-probability' patient allows for the safe exclusion of VTE. A positive D-dimer is not diagnostic of VTE; it merely necessitates further imaging (e.g., Doppler Ultrasound or CTPA). In older patients, age-adjusted cutoffs (age × 10 for those over 50 years) are often used to increase the specificity of the test, as D-dimer levels naturally rise with age.

A raised D-dimer (>500 ng/mL or age-adjusted threshold) indicates increased fibrin split products in the circulation. While classic for VTE, very high levels are also seen in Disseminated Intravascular Coagulation (DIC), where there is widespread systemic activation of clotting and fibrinolysis. Levels also rise significantly in pregnancy, malignancy, recent surgery, trauma, and severe infections (including COVID-19), making the test non-specific for thrombosis in these groups.

The primary clinical utility of D-dimer is its high 'Negative Predictive Value' (NPV). In a patient with a low or intermediate clinical probability (Wells score) of DVT or PE, a negative D-dimer effectively rules out the diagnosis without the need for expensive or invasive imaging (like CTPA). It is a central component of the diagnostic algorithms for venous thromboembolism in emergency and primary care settings.

Choosing the wrong patient for the test is the biggest pitfall; ordering a D-dimer for a patient with a high clinical probability or for someone who is 3 days post-major surgery is inappropriate and leads to unnecessary anxiety and further testing. Additionally, small distal clots (like isolated calf vein DVT) or very old clots may not produce enough D-dimer to trigger a positive result, leading to a false negative.

The test has very low specificity, meaning many conditions other than VTE can cause a positive result. It should not be performed in patients with a high clinical probability of VTE, as a negative result in that context is not reliable enough to rule out the condition. It is also of limited use in patients who have been on anticoagulants for several days, as this can suppress D-dimer production and lead to false negatives.

The D-dimer is a 'rule-out' test, not a 'rule-in' test. Students must remember the Wells Score: never order a D-dimer if the Wells score indicates high probability—go straight to imaging. Age-adjusting the D-dimer (for >50s) is a frequent exam pearl.